Influenza-like illness. Therapeutic experience in family medicine
Main Article Content
Keywords
Influenza, human, Respiratory tract infections
Abstract
Background: influenza is a highly contagious respiratory disease. Surveillance in Mexico is based on the detection of Influenza-Like Illness (ILI) and antiviral treatment should begin within 48 hours to avoid the main complication, pneumonia. The aim was to describe the experience on treatment of the ILI in a family medicine unit.
Methods: a descriptive study included patients presented to the emergency room with ILI (38ºC fever, headache and cough accompanied by other symptoms). We reviewed the reporting formats of Influenza. To follow up, contact them by telephone. Data are expressed as mean ± standard deviation.
Results: there were 537 patients attended with diagnosis of upper airway infection, 1.3 % met criteria for ILI. 85.7 % were men. The mean age was 18 ± 24.21 years. The patients were seen in a mean time of 19.14 hours after the symptoms have started; 100 % of the patients received treatment with oseltamivir and zanamivir; 14.3 % developed pneumonia. All the patients recovered without concomitant disease or complications.
Conclusions: The use of a protocol in patients with influenza in a family medicine unit led an early diagnosis and treatment that favored the patients’ health restoration.
References
Secretaría de Salud. Lineamientos para la Vigilancia Epidemiológica de Influenza. México: Sinave; 2012. Texto libre en http://www.dgepi.salud.gob.mx/influenza/2012/Linea_Influenza.pdf
Dirección General de Epidemiología. Manual para la vigilancia epidemiológica de la influenza. Segunda edición. México: Secretaría de Salud; 2007.
Instituto Mexicano del Seguro Social. Guía de referencia rápida. Prevención, diagnóstico y tratamiento de la influenza A H1N1. México: IMSS; 2009. Texto libre en http://www.imss.gob.mx/profesionales/guiasclinicas/Documents/000GRR_H1N1.pdf
Centro Universitario de Ciencias de la Salud. Observatorio de la Salud. [Sitio web]. Influenza humana AH1N1. México: Universidad de Guadalajara. Disponible en http://www.cucs.udg.mx/observatorio/files/File/Influenza_humana3.pdf
Centers for Disease Control and Prevention. Intensive-care patients with severe novel influenza A (H1N1) virus infection. Michigan, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(27):749-52.
Secretaría de Salud. Situación actual de la epidemia. México: Secretaría de Salud; 2010. Disponible en http://portal.salud.gob.mx/contenidos/noticias/influenza/estadisticas.html
De la Torre A, Macías AE, López-Gatell H, et al. Centinelas de la influenza pandémica en México: Perspectivas de la vigilancia epidemiológica y el control. Rev Digit Univ. 2010;11(04):1067-79. Texto libre en http://www.revista.unam.mx/vol.11/num4/art40/
Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial. Neuraminidase inhibitor Flu treatment investigator group. Lancet. 2000;355:1845-50.
Centers for Disease Control and Prevention. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients-Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep. 2009;58 (Dispatch):1-4. Texto libre en http://www.cdc.gov/mmwr/preview/mmwrhtml/mm58d0814a1.htm
Centers for Disease Control and Prevention. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis, North Carolina, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(35):969-72. Texto libre en http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5835a1.htm
López-Suñe E, Tuset M, Laguno M, et al. Características de los fármacos antivíricos activos frente al virus de la hepatitis y el virus de la influenza: actualización 2009. Enferm Infecc Microbiol Clin. 2010;28 (4):253.e1-17
Navarro-Marín JM, Mayoral-Cortés JM, et al. Infección en humanos por virus de la gripe A (H1N1). Enferm Infecc Microbiol Clin. 2010;28(7):446-52.
Secretaría de Salud. [Sitio web]. Ley General de Salud. México: Secretaria de Salud; 1993. Disponible en http://www.salud.gob.mx/unidades/cdi/legis/lgs/index-indice.htm
Norma Oficial Mexicana NOM-017-SSA2-1994, para la vigilancia epidemiológica. México: Secretaria de Salud; 1994. Texto libre en http://www.salud.gob.mx/unidades/cdi/nom/017ssa24.html